These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28746336)

  • 1. Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.
    Yi B; Jahangir A; Evans AK; Briggs D; Ravina K; Ernest J; Farimani AB; Sun W; Rajadas J; Green M; Feinberg EN; Pande VS; Shamloo M
    PLoS One; 2017; 12(7):e0180319. PubMed ID: 28746336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
    Warne T; Moukhametzianov R; Baker JG; Nehmé R; Edwards PC; Leslie AG; Schertler GF; Tate CG
    Nature; 2011 Jan; 469(7329):241-4. PubMed ID: 21228877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro evaluation of derivatives of the β₁-adrenergic receptor antagonist HX-CH 44.
    Stephenson KA; Wilson AA; Houle S; Vasdev N
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5506-9. PubMed ID: 21783363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of structurally novel G protein biased CB
    Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
    Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of phosphorylation sites on β1-adrenergic receptor in the mouse heart.
    Hayashi K; Gotou M; Matsui T; Imahashi K; Nishimoto T; Kobayashi H
    Biochem Biophys Res Commun; 2017 Jun; 488(2):362-367. PubMed ID: 28501616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
    Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
    PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of functionally selective, small molecule agonists at kappa opioid receptors.
    Zhou L; Lovell KM; Frankowski KJ; Slauson SR; Phillips AM; Streicher JM; Stahl E; Schmid CL; Hodder P; Madoux F; Cameron MD; Prisinzano TE; Aubé J; Bohn LM
    J Biol Chem; 2013 Dec; 288(51):36703-16. PubMed ID: 24187130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interhelical interaction and receptor phosphorylation regulate the activation kinetics of different human β1-adrenoceptor variants.
    Ahles A; Rodewald F; Rochais F; Bünemann M; Engelhardt S
    J Biol Chem; 2015 Jan; 290(3):1760-9. PubMed ID: 25451930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M
    Broad LM; Sanger HE; Mogg AJ; Colvin EM; Zwart R; Evans DA; Pasqui F; Sher E; Wishart GN; Barth VN; Felder CC; Goldsmith PJ
    Br J Pharmacol; 2019 Jan; 176(1):110-126. PubMed ID: 30276808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
    Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
    Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists.
    Mistry SN; Baker JG; Fischer PM; Hill SJ; Gardiner SM; Kellam B
    J Med Chem; 2013 May; 56(10):3852-65. PubMed ID: 23614528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.
    Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H
    Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noribogaine is a G-protein biased κ-opioid receptor agonist.
    Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
    Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-expression β(1) adrenergic receptor/cell membrane chromatography method based on a target receptor to screen active ingredients from traditional Chinese medicines.
    Yue Y; Xue H; Wang X; Yang Q; Song Y; Li X
    J Sep Sci; 2014 Feb; 37(3):244-9. PubMed ID: 24272943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
    Chen X; McCorvy JD; Fischer MG; Butler KV; Shen Y; Roth BL; Jin J
    J Med Chem; 2016 Dec; 59(23):10601-10618. PubMed ID: 27805392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.